한글목차

희소 혈액학 시장, 2024-2028년

희소 혈액학 시장은 2023-2028년에 45억 8,510만 달러, 예측 기간 중 CAGR은 5.7%로 성장할 것으로 예측됩니다. 희소 혈액학 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 전략적 포트폴리오의 강화, 희귀 혈액암에서 유전자 변이에 대한 주목의 증가, 희귀 혈액 질환의 진보에 의해 촉진되고 있습니다.

본 조사에서는 향후 수년간 희소 혈액학 시장의 성장을 촉진하는 주요 이유의 하나로 식품의약국(FDA)에 의한 승인을 들고 있습니다. 또한 현대화된 임상시험 방법의 채택 증가 및 업계 협업의 확대도 이 시장의 큰 수요로 연결됩니다.

목차

제1장 개요

• 시장 개요

제2장 Technavio 분석

• 가격·수명주기·고객 구입 바스켓·채택률·구입 기준 분석
• 인풋의 중요성과 차별화의 요인
• 혼란의 요인
• 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 에코시스템
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모의 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장의 전망 2023-2028년

제5장 시장 규모 실적

• 세계의 희소 혈액학 시장 2018-2022년
• 질환 유형별 부문 분석 2018-2022년
• 최종사용자별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제6장 정성 분석

• 세계의 희소 혈액학 시장에 대한 인공지능(AI)의 영향

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제8장 시장 세분화 : 질환 유형별

• 시장 세분화
• 비교 : 질환 유형별
• 혈우병 : 시장 규모와 예측 2023-2028년
• 겸상 적혈구증 : 시장 규모와 예측 2023-2028년
• 지중해빈혈 : 시장 규모와 예측 2023-2028년
• 골수이형성증후군 : 시장 규모와 예측 2023-2028년
• 질병 유형별 시장 기회

제9장 시장 세분화 : 최종사용자별

• 시장 세분화
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측 2023-2028년
• 전문 클리닉 : 시장 규모와 예측 2023-2028년
• 연구기관 : 시장 규모와 예측 2023-2028년
• 제약회사 : 시장 규모와 예측 2023-2028년
• 최종사용자별 시장 기회

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 영국 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 일본 : 시장 규모와 예측 2023-2028년
• 인도 : 시장 규모와 예측 2023-2028년
• 프랑스 : 시장 규모와 예측 2023-2028년
• 이탈리아 : 시장 규모와 예측 2023-2028년
• 한국 : 시장 규모와 예측 2023-2028년
• 싱가포르 : 시장 규모와 예측 2023-2028년
• 지역 상황별 시장 기회

제12장 촉진요인·과제·기회·억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장의 기회·억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계의 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• AstraZeneca Plc
• Bayer AG
• bluebird bio Inc.
• Bristol Myers Squibb Co.
• CSL Ltd.
• F. Hoffmann La Roche Ltd.
• Jazz Pharmaceuticals Plc
• Johnson and Johnson Services Inc.
• Merck and Co. Inc.
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

제15장 부록

영문목차

Rare Hematology Market 2024-2028

The rare hematology market is forecasted to grow by USD 4585.1 million during 2023-2028, accelerating at a CAGR of 5.7% during the forecast period. The report on the rare hematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by enhancement of strategic portfolios, growing focus on genetic variants in rare blood cancers, and prevalence of rare hematologic disorders.

Technavio's rare hematology market is segmented as below:

By Disease Type

• Hemophilia
• Sickle cell disease
• Thalassemia
• Myelodysplastic syndromes

By End-user

• Hospitals
• Specialty clinics
• Research institutes
• Pharmaceutical companies

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the approvals from food and drug administration (FDA) as one of the prime reasons driving the rare hematology market growth during the next few years. Also, increasing adoption of modernized clinical trial methods and expansion of industry collaborations will lead to sizable demand in the market.

The report on the rare hematology market covers the following areas:

• Rare Hematology Market sizing
• Rare Hematology Market forecast
• Rare Hematology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rare hematology market vendors that include AbbVie Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., bluebird bio Inc., Bristol Myers Squibb Co., CSL Ltd., Emmaus Medical Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Grifols SA, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Octapharma AG, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the rare hematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Rare Hematology Market 2018 - 2022
  • Historic Market Size - Data Table on Global Rare Hematology Market 2018 - 2022 ($ million)
• 5.2 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
• 5.3 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 5.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

• 6.1 Impact of Artificial Intelligence (AI) in the global rare hematology market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 7.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Disease Type

• 8.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)
• 8.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type
• 8.3 Hemophilia - Market size and forecast 2023-2028
  • Chart on Hemophilia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hemophilia - Market size and forecast 2023-2028 ($ million)
  • Chart on Hemophilia - Year-over-year growth 2023-2028 (%)
  • Data Table on Hemophilia - Year-over-year growth 2023-2028 (%)
• 8.4 Sickle cell disease - Market size and forecast 2023-2028
  • Chart on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
  • Data Table on Sickle cell disease - Market size and forecast 2023-2028 ($ million)
  • Chart on Sickle cell disease - Year-over-year growth 2023-2028 (%)
  • Data Table on Sickle cell disease - Year-over-year growth 2023-2028 (%)
• 8.5 Thalassemia - Market size and forecast 2023-2028
  • Chart on Thalassemia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Thalassemia - Market size and forecast 2023-2028 ($ million)
  • Chart on Thalassemia - Year-over-year growth 2023-2028 (%)
  • Data Table on Thalassemia - Year-over-year growth 2023-2028 (%)
• 8.6 Myelodysplastic syndromes - Market size and forecast 2023-2028
  • Chart on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
  • Data Table on Myelodysplastic syndromes - Market size and forecast 2023-2028 ($ million)
  • Chart on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
  • Data Table on Myelodysplastic syndromes - Year-over-year growth 2023-2028 (%)
• 8.7 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2023-2028
  • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 9.4 Specialty clinics - Market size and forecast 2023-2028
  • Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
  • Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
  • Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
  • Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
• 9.5 Research institutes - Market size and forecast 2023-2028
  • Chart on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Data Table on Research institutes - Market size and forecast 2023-2028 ($ million)
  • Chart on Research institutes - Year-over-year growth 2023-2028 (%)
  • Data Table on Research institutes - Year-over-year growth 2023-2028 (%)
• 9.6 Pharmaceutical companies - Market size and forecast 2023-2028
  • Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 11.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 11.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 11.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 11.8 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 11.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 11.10 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 11.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 11.12 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 11.13 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
• 11.14 Italy - Market size and forecast 2023-2028
  • Chart on Italy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Italy - Market size and forecast 2023-2028 ($ million)
  • Chart on Italy - Year-over-year growth 2023-2028 (%)
  • Data Table on Italy - Year-over-year growth 2023-2028 (%)
• 11.15 South Korea - Market size and forecast 2023-2028
  • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
• 11.16 Singapore - Market size and forecast 2023-2028
  • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 14.5 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 14.6 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 14.7 bluebird bio Inc.
  • bluebird bio Inc. - Overview
  • bluebird bio Inc. - Product / Service
  • bluebird bio Inc. - Key offerings
  • SWOT
• 14.8 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 14.9 CSL Ltd.
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key news
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Segment focus
  • SWOT
• 14.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 14.11 Jazz Pharmaceuticals Plc
  • Jazz Pharmaceuticals Plc - Overview
  • Jazz Pharmaceuticals Plc - Product / Service
  • Jazz Pharmaceuticals Plc - Key news
  • Jazz Pharmaceuticals Plc - Key offerings
  • SWOT
• 14.12 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 14.13 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 14.14 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 14.15 Novo Nordisk AS
  • Novo Nordisk AS - Overview
  • Novo Nordisk AS - Business segments
  • Novo Nordisk AS - Key offerings
  • Novo Nordisk AS - Segment focus
  • SWOT
• 14.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 14.17 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 14.18 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations